Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 8/20 | 0.37 |
| ▸ | MAOA | P21397 | 7/20 | 0.37 |
| ▸ | KDM1A | O60341 | 5/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22209814 | 0.98 | GAA (0.43) | GAAMAPTSLC18A3SIGMAR1AKR1C3 | |
| SCHEMBL10177659 | 0.83 | AKR1C3 (0.47) | GAAMAPTSLC18A3SIGMAR1AKR1C3 | |
| SCHEMBL1399510 | 0.80 | AKR1C3 (0.41) | SLC18A3SIGMAR1AKR1C3AKR1C1 | |
| SCHEMBL10177633 | 0.80 | AKR1C3 (0.41) | SLC18A3SIGMAR1AKR1C3AKR1C1 | |
| SCHEMBL10177636 | 0.80 | AKR1C3 (0.41) | SLC18A3SIGMAR1AKR1C3AKR1C1 | |
| SCHEMBL26302859 | 0.79 | CHRNB4 (0.42) | GAAMAPTSLC18A3SIGMAR1MAOB | |
| SCHEMBL26302858 | 0.79 | CHRNB4 (0.42) | GAAMAPTSLC18A3SIGMAR1MAOB | |
| SCHEMBL31435485 | 0.79 | CHRNB4 (0.42) | GAAMAPTSLC18A3SIGMAR1MAOB | |
| SCHEMBL1399533 | 0.78 | SLC18A3 (0.48) | GAAMAPTSLC18A3SIGMAR1AKR1C3 | |
| SCHEMBL10343084 | 0.78 | SLC18A3 (0.48) | GAAMAPTSLC18A3SIGMAR1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1882282-B1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY USING THE SAME | LG CHEMICAL LTD (KR) | 2011-03-02 | — | — | EP | disclosed |
| US-20100099905-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY USING THE SAME | LG CHEM, LTD. (KR) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099905-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY USING THE SAME | HCN2, HCN3, NHERF1 | GAA 2624/4885MAPT 4733/4885SLC18A3 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.